Purchase Order 1232SC18P0203
- Not listed
- The U.S. civilian federal government awarded a $3,500 firm fixed-price purchase order for DNA sequencing services to Psomagen Inc., a genomics and molecular biology services company based in Rockville, Maryland and subsidiary of Macrogen, Inc. The contract, awarded on April 10, 2018, with performance to be completed by the same date, represents a ratifying order with no small business set-aside designation. Work is to be performed in Potomac, Maryland. Psomagen specializes in advanced genomic...
- The U.S. government awarded a $12.5K firm fixed-price purchase order to Psomagen Inc. for sequencing services on April 15, 2016. The contract, which was not designated as a set-aside, was funded by a civilian agency within the Southeast Area and required performance in Potomac, Maryland, with an ultimate completion date of September 30, 2017. Psomagen Inc., a genomics and molecular biology services company based in Rockville, Maryland, and a subsidiary of Macrogen Inc., provided the sequencing...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $10,000.00 firm fixed-price purchase order is for DNA sequencing services. The contract has no set-aside designation. Psomagen Inc. is a provider of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, that supports...
- This federal contract award to Psomagen Inc., a subsidiary of Macrogen, Inc., is for epigenome sequencing services using the Illumina NovaSeq platform. The $83,750 firm fixed-price purchase order was awarded by the National Institute on Aging, a civilian agency within the National Institutes of Health. The award was not set aside for small businesses. Psomagen Inc. is an experienced provider of genomic services to federal agencies, having supported research initiatives at the NIH, USDA, and...
- This federal contract award is for $313,500.00 in single cell multiome sequencing services, provided by Psomagen Inc., a subsidiary of Macrogen, Inc. The contract was awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH). The contract is a firm fixed price purchase order with a period of performance through March 1, 2026. Psomagen Inc. is a prime contractor that specializes in delivering a wide range of genomic and molecular biology...
- This federal contract award was issued by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $4,250 firm fixed-price purchase order was for unspecified genomic and molecular biology services to support research initiatives at NHGRI. Psomagen Inc. has established itself as a key provider of advanced sequencing and omics capabilities to federal agencies, having been awarded numerous...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $30,000 firm fixed-price purchase order was not set aside for any specific business type. Under this contract, Psomagen will provide a range of genomic and molecular biology services to support research across various NIH institutes, including the National Institute on Aging,...
- This federal contract award, with a ceiling value of $27,600, was issued by the National Institute of Mental Health (NIMHD) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for bioinformatics services related to RNA/DNA sequencing. Psomagen, a small business, has a history of providing genomic services to various federal agencies, including the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and Smithsonian Institution, through both contract and...
- This is a firm fixed-price purchase order awarded by the National Institute of Mental Health (NIMH), a civilian agency, to Psomagen Inc., a genomics and molecular biology services company based in Rockville, Maryland. The $180,000 contract has a period of performance ending on May 19, 2025. Psomagen Inc. is a subsidiary of the parent company Macrogen, Inc., which is a leading provider of genomic sequencing and bioinformatics services to the U.S. federal government. The contract does not have a...
- This federal contract, awarded by the National Institute on Aging (a civilian agency of the U.S. government), is for the purchase of whole genome sequencing services from the prime contractor, Psomagen Inc. The contract has a total ceiling value of $7,499,725.00 and is set aside for small businesses. Psomagen Inc. is a subsidiary of Macrogen, Inc. that specializes in providing a range of genomic sequencing, bioinformatics, and related services to federal agencies. Through this contract, Psomagen...
This federal contract represents a ratifying order for sequencing services awarded to Psomagen Inc., a genomics and molecular biology services company subsidiary of Macrogen, Inc., on April 10, 2018. The purchase order carries a ceiling value of $2,718.65 under a firm fixed-price contract type with no set-aside designation. The work will be performed in Potomac, Maryland, and is funded by a civilian federal agency's Southeast Area office. Psomagen specializes in advanced genomic sequencing, bioinformatics, and multi-omics data analysis services, operating CLIA-certified and CAP-accredited facilities that support critical research initiatives across federal agencies. This award reflects Psomagen's established capability to deliver specialized sequencing services to the federal government. The contractor's experience spans engagements with the National Institutes of Health, U.S. Department of Agriculture, Food and Drug Administration, and the Smithsonian Institution, supporting research in areas including neurodegenerative diseases, infectious diseases, precision medicine, and agricultural genetics. Notably, Psomagen holds significant indefinite delivery vehicles with federal agencies, including a $500 million single-award contract with the National Heart, Lung and Blood Institute for the Trans-Omics for Precision Medicine (TOPMed) initiative, positioning the company as a key provider of sophisticated genomic research services within the federal contracting landscape.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 4/10/18 |